Cancer societies for healthcare professionals
European Society for Medical Oncology (ESMO)
Via L. Taddei 46962 Viganello-Lugano
Switzerland
Tel: +41 (0)91 973 19 00
Fax: +41 (0)91 973 19 02
Web: Click here
American Society of Clinical Oncology (ASCO)
2318 Mill RoadSuite 800
Alexandria, VA 22314
USA
Tel: +1 571 483 1300
Web: Click here
Guidelines
ESMO colorectal cancer guidelines
Schmoll HJ, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer: a personalised approach to clinical decision making. Ann Oncol 2012;23:2479-2516.
Web: Click here
Expert Group on OncoSurgery management of Liver Metastases (EGOSLIM) colorectal cancer guidelines on liver metastases
Adam R et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012;17(10):1225-1239.
Web: Click here
Key Vectibix® references
The PRIME study
Douillard J-Y et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med 2013;369:1023-1034.
Web: Click here
The PEAK study
Schwartzberg L et al. PEAK: A randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer. J Clin Oncol 2014, March 31 (published online before print).
Web: Click here
Other useful links
Management of skin toxicity with anti- EGFR treatment
ESMO: Management of skin toxicities from EGFR inhibitor therapies (for healthcare professionals).
Web: Click here
European Medicines Agency
European Public Assessment Report (EPAR) for Vectibix®
Web: Click here